EA200000322A1 - Способ синтеза производных хинолина - Google Patents
Способ синтеза производных хинолинаInfo
- Publication number
- EA200000322A1 EA200000322A1 EA200000322A EA200000322A EA200000322A1 EA 200000322 A1 EA200000322 A1 EA 200000322A1 EA 200000322 A EA200000322 A EA 200000322A EA 200000322 A EA200000322 A EA 200000322A EA 200000322 A1 EA200000322 A1 EA 200000322A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- synthesis
- quinoline derivatives
- carboxamine
- phenylquinoline
- ethylbenzyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
- C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
Abstract
Данное изобретение относится к новым промежуточным веществам и способам получения фармацевтически активных соединений хинолина, включая (-)-(S)-N-(α-этилбензил)-3-гидрокси-2-фенилхинолин-4-карбоксамид.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5930397P | 1997-09-17 | 1997-09-17 | |
PCT/US1998/019434 WO1999014196A1 (en) | 1997-09-17 | 1998-09-17 | Method for the synthesis of quinoline derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200000322A1 true EA200000322A1 (ru) | 2000-10-30 |
EA002633B1 EA002633B1 (ru) | 2002-08-29 |
Family
ID=22022126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200000322A EA002633B1 (ru) | 1997-09-17 | 1998-09-17 | Способ синтеза производных хинолина |
Country Status (32)
Country | Link |
---|---|
US (6) | US6335448B1 (ru) |
EP (1) | EP1017676B1 (ru) |
JP (1) | JP2001516744A (ru) |
KR (1) | KR20010024031A (ru) |
CN (1) | CN1125815C (ru) |
AP (1) | AP1201A (ru) |
AR (1) | AR015445A1 (ru) |
AT (1) | ATE353879T1 (ru) |
AU (1) | AU744538B2 (ru) |
BG (1) | BG104243A (ru) |
BR (1) | BR9812085A (ru) |
CA (1) | CA2303026A1 (ru) |
DE (1) | DE69837100T2 (ru) |
DZ (1) | DZ2607A1 (ru) |
EA (1) | EA002633B1 (ru) |
ES (1) | ES2283072T3 (ru) |
HU (1) | HUP0004855A3 (ru) |
ID (1) | ID24140A (ru) |
IL (1) | IL134991A0 (ru) |
MA (1) | MA24644A1 (ru) |
MY (1) | MY120237A (ru) |
NO (1) | NO314303B1 (ru) |
NZ (1) | NZ503307A (ru) |
OA (1) | OA11340A (ru) |
PE (1) | PE129299A1 (ru) |
PL (1) | PL339340A1 (ru) |
SK (1) | SK3672000A3 (ru) |
TR (1) | TR200000720T2 (ru) |
TW (1) | TW509678B (ru) |
UY (2) | UY25174A1 (ru) |
WO (1) | WO1999014196A1 (ru) |
ZA (1) | ZA988455B (ru) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP1201A (en) * | 1997-09-17 | 2003-09-01 | Smithkline Beecham Corp | Method for the synthesis of quinoline derivatives. |
CA2368455A1 (en) | 1999-03-29 | 2000-10-05 | Neurogen Corporation | 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands |
CA2555133A1 (en) | 2004-02-04 | 2005-09-01 | Pfizer Products Inc. | Substituted quinoline compounds |
KR20080016591A (ko) * | 2005-06-03 | 2008-02-21 | 아스트라제네카 아베 | Nk3 길항제로서의 퀴놀린 유도체 |
US20080194623A1 (en) * | 2005-08-02 | 2008-08-14 | Labaw Clifford S | Method for the Synthesis of Quinoline Derivatives |
EP1915363A1 (en) * | 2005-08-11 | 2008-04-30 | AstraZeneca AB | Oxopyridyl quinoline amides as nk3 receptor modulators |
CN101268052A (zh) * | 2005-09-21 | 2008-09-17 | 阿斯利康(瑞典)有限公司 | 作为nk-3受体配体的n-氧代-杂环和n-氧代-烷基喹啉-4-甲酰胺 |
AR057130A1 (es) * | 2005-09-21 | 2007-11-14 | Astrazeneca Ab | Quinolinas de alquilsulfoxido y una composicion farmaceutica |
WO2007086799A1 (en) * | 2006-01-27 | 2007-08-02 | Astrazeneca Ab | Amide substituted quinolines |
CN102924375B (zh) * | 2012-06-21 | 2015-02-18 | 江苏恩华药业股份有限公司 | Talnetant中间体及其制备方法和应用 |
CN102702099A (zh) * | 2012-06-21 | 2012-10-03 | 江苏恩华药业股份有限公司 | (s)-3-羟基-2-苯基-n-(1-苯基丙基)喹啉-4-甲酰胺的制备方法 |
CN103214416A (zh) * | 2013-04-26 | 2013-07-24 | 扬州大学 | 一种合成多取代喹啉类化合物的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2776290A (en) * | 1957-01-01 | Hydroxy cevchoninates and carboxylic | ||
NZ287442A (en) * | 1994-05-27 | 1998-05-27 | Smithkline Beecham Spa | 4-substituted quinoline derivatives; medicaments; use as an nk3 receptor antagonist |
US5627193A (en) * | 1995-02-09 | 1997-05-06 | Mitsui Toatsu Chemicals, Inc. | Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds |
AP1201A (en) * | 1997-09-17 | 2003-09-01 | Smithkline Beecham Corp | Method for the synthesis of quinoline derivatives. |
-
1998
- 1998-05-08 AP APAP/P/2000/001767A patent/AP1201A/en active
- 1998-09-08 MA MA25246A patent/MA24644A1/fr unknown
- 1998-09-08 UY UY25174A patent/UY25174A1/es not_active Application Discontinuation
- 1998-09-11 PE PE1998000868A patent/PE129299A1/es not_active Application Discontinuation
- 1998-09-14 DZ DZ980217A patent/DZ2607A1/xx active
- 1998-09-15 MY MYPI98004207A patent/MY120237A/en unknown
- 1998-09-16 ZA ZA988455A patent/ZA988455B/xx unknown
- 1998-09-16 AR ARP980104603A patent/AR015445A1/es not_active Application Discontinuation
- 1998-09-17 JP JP2000511747A patent/JP2001516744A/ja active Pending
- 1998-09-17 US US09/508,358 patent/US6335448B1/en not_active Expired - Fee Related
- 1998-09-17 NZ NZ503307A patent/NZ503307A/en unknown
- 1998-09-17 EA EA200000322A patent/EA002633B1/ru not_active IP Right Cessation
- 1998-09-17 PL PL98339340A patent/PL339340A1/xx unknown
- 1998-09-17 AU AU93958/98A patent/AU744538B2/en not_active Ceased
- 1998-09-17 BR BR9812085-9A patent/BR9812085A/pt not_active IP Right Cessation
- 1998-09-17 HU HU0004855A patent/HUP0004855A3/hu unknown
- 1998-09-17 TR TR2000/00720T patent/TR200000720T2/xx unknown
- 1998-09-17 EP EP98947099A patent/EP1017676B1/en not_active Expired - Lifetime
- 1998-09-17 ID IDW20000498A patent/ID24140A/id unknown
- 1998-09-17 IL IL13499198A patent/IL134991A0/xx unknown
- 1998-09-17 DE DE69837100T patent/DE69837100T2/de not_active Expired - Lifetime
- 1998-09-17 SK SK367-2000A patent/SK3672000A3/sk unknown
- 1998-09-17 WO PCT/US1998/019434 patent/WO1999014196A1/en active IP Right Grant
- 1998-09-17 KR KR1020007002766A patent/KR20010024031A/ko not_active Application Discontinuation
- 1998-09-17 CN CN98810978A patent/CN1125815C/zh not_active Expired - Fee Related
- 1998-09-17 AT AT98947099T patent/ATE353879T1/de not_active IP Right Cessation
- 1998-09-17 CA CA002303026A patent/CA2303026A1/en not_active Abandoned
- 1998-09-17 ES ES98947099T patent/ES2283072T3/es not_active Expired - Lifetime
- 1998-09-29 TW TW087114858A patent/TW509678B/zh not_active IP Right Cessation
-
1999
- 1999-02-26 UY UY25407A patent/UY25407A1/es unknown
-
2000
- 2000-03-15 BG BG104243A patent/BG104243A/xx unknown
- 2000-03-16 NO NO20001387A patent/NO314303B1/no not_active IP Right Cessation
- 2000-03-16 OA OA1200000078A patent/OA11340A/en unknown
-
2001
- 2001-10-17 US US09/981,185 patent/US20020038029A1/en not_active Abandoned
-
2002
- 2002-06-17 US US10/174,458 patent/US20020173657A1/en not_active Abandoned
-
2003
- 2003-05-20 US US10/441,708 patent/US20040049031A1/en not_active Abandoned
-
2005
- 2005-03-30 US US11/093,701 patent/US20050171152A1/en not_active Abandoned
-
2006
- 2006-04-28 US US11/413,932 patent/US20060189809A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200100971A1 (ru) | Новые соединения и композиции в качестве ингибиторов протеазы | |
DE69926806D1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
EA200100780A1 (ru) | Антагонисты tweak и рецептора tweak и их использование для лечения иммунологических заболеваний | |
EA200200873A1 (ru) | Новые пиперазиновые производные | |
NO20030845D0 (no) | Utvalgte fusjonerte pyrrolokarbazoler | |
DE69926919D1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
BG66085B1 (bg) | Фенилаланинови производни | |
BR9712085A (pt) | Inibidores de metaloprotease heterocìclicos | |
EA200100012A1 (ru) | Мостиковые инденопирролокарбазолы | |
EA200301223A1 (ru) | Лекарственные формы окскарбазепина | |
EA199900279A1 (ru) | Производные бензамида и их применение в качестве лекарственных средств с лтв4-антагонистической активностью | |
EA200000322A1 (ru) | Способ синтеза производных хинолина | |
EA199700253A1 (ru) | Производные нодулиспоровой кислоты | |
EA200301276A1 (ru) | Новые производные сульфоновых кислот | |
NO20061575L (no) | Fremgangsmate for fremstilling av renzapride og mellomprodukter derav | |
EA200000094A1 (ru) | Способ получения замещенного пергидроизоиндола | |
DK1274685T3 (da) | Et pyridin-N-oxid-derivat og fremgangsmåde til omdannelse deraf til farmaceutisk effektive forbindelser | |
EA199800034A1 (ru) | Способ получения n-монозамещенных и n,n'-дизамещенных асимметричных циклических мочевин | |
EA200200101A1 (ru) | Получение замещенных пиперидин-4-онов | |
EA199900235A1 (ru) | Аморфные бензотиофены, способы получения и способы применения | |
EA200101106A1 (ru) | Фармацевтический комплекс | |
EA200201232A1 (ru) | Производные сульфонамида | |
EA200200749A1 (ru) | Производные гетероциклического амида | |
EA200101180A1 (ru) | Производные тио-оксиндола | |
EA200301133A1 (ru) | Способ получения дифторбензилэпоксидов и промежуточные соединения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |